Publications Office of the EU
Drug discount agreement pursuant to § 130c(1) SGB V on the active substance combination vilanterol and umeclidinium bromide - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Drug discount agreement pursuant to § 130c(1) SGB V on the active substance combination vilanterol and umeclidinium bromide Text automatically translated in your browsing language Automatically translated

Overview
  • Awarded
    20/11/2024
  • Today
    17/03/2025
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
AOK Baden-Württemberg
Place of performance
NUTS code: Multiple place of performance
Location of buyer
NUTS code: DE111 Stuttgart, Stadtkreis
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
Not available
Total final contract value (excluding VAT)
221,000.00 EUR
Procedure details
Tender reference number
Arzneimittelrabattvereinbarung gemäß § 130c Abs. 1 SGB V zu der Wirkstoffkombination Vilanterol und Umeclidiniumbromid
Description

Agreement pursuant to § 130c(1) SGB V on the granting of discounts for patented medicinal products with the active ingredient combination vilanterol and umeclidinium bromide (Anoro® Ellipta® / Laventair® Ellipta®). An exact contract value cannot be determined, as this depends on various unknown factors. The contract value for the contract awarded can therefore only be specified as a notional value based on the currently applicable thresholds. Text automatically translated in your browsing language Automatically translated

Submission Method
Not available
Tenders may be submitted
Not available
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The procurement involves the establishment of a framework agreement
Conditions for opening tenders (date)
Not available
Place of performance
DE Deutschland
DE111 Stuttgart, Stadtkreis
CPV code

33600000 - Pharmaceutical products

Award method
Criterion:
Type: price
Description: Der Preis ist nicht das einzige Zuschlagskriterium.
Weight (percentage, exact):
Estimated value
Not available
Final contracted value
221,000.00 EUR
Award of contract
Official name: GlaxoSmithKline GmbH & Co. KG
Postal address:
Town: München
Postal code: 81675
Country:
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.